Titre : ATP-dependent proteases

ATP-dependent proteases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cornea
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "ATP-dependent proteases : Questions médicales les plus fréquentes", "headline": "ATP-dependent proteases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les ATP-dependent proteases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-23", "dateModified": "2025-02-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "ATP-dependent proteases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "ATPases associated with diverse cellular activities", "url": "https://questionsmedicales.fr/mesh/D000074183", "about": { "@type": "MedicalCondition", "name": "ATPases associated with diverse cellular activities", "code": { "@type": "MedicalCode", "code": "D000074183", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ATP-dependent endopeptidases", "alternateName": "ATP-Dependent Endopeptidases", "url": "https://questionsmedicales.fr/mesh/D057065", "about": { "@type": "MedicalCondition", "name": "ATP-dependent endopeptidases", "code": { "@type": "MedicalCode", "code": "D057065", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750.032.099" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Protease La", "alternateName": "Protease La", "url": "https://questionsmedicales.fr/mesh/D049070", "about": { "@type": "MedicalCondition", "name": "Protease La", "code": { "@type": "MedicalCode", "code": "D049070", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.157.025.750.032.099.750" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "ATP-dependent proteases", "alternateName": "ATP-Dependent Proteases", "code": { "@type": "MedicalCode", "code": "D049069", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Zhou Sha", "url": "https://questionsmedicales.fr/author/Zhou%20Sha", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, 44106, USA." } }, { "@type": "Person", "name": "Jennifer Fishovitz", "url": "https://questionsmedicales.fr/author/Jennifer%20Fishovitz", "affiliation": { "@type": "Organization", "name": "Department of Chemistry and Physics, Saint Mary's College, Notre Dame, Indiana, 46556, USA." } }, { "@type": "Person", "name": "Sujatha Chilakala", "url": "https://questionsmedicales.fr/author/Sujatha%20Chilakala", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Cleveland State University, Cleveland, Ohio, 44115, USA." } }, { "@type": "Person", "name": "Yan Xu", "url": "https://questionsmedicales.fr/author/Yan%20Xu", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Cleveland State University, Cleveland, Ohio, 44115, USA." } }, { "@type": "Person", "name": "Irene Lee", "url": "https://questionsmedicales.fr/author/Irene%20Lee", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, 44106, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Layer-by-Layer Investigation of Ultrastructures and Biomechanics of Human Cornea.", "datePublished": "2022-07-15", "url": "https://questionsmedicales.fr/article/35887181", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms23147833" } }, { "@type": "ScholarlyArticle", "name": "Investigation of microstructural failure in the human cornea through fracture tests.", "datePublished": "2023-08-24", "url": "https://questionsmedicales.fr/article/37620375", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-40286-3" } }, { "@type": "ScholarlyArticle", "name": "New ZNF469 Mutations in Spanish Siblings With Brittle Cornea Syndrome.", "datePublished": "2023-04-24", "url": "https://questionsmedicales.fr/article/37098112", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/ICO.0000000000003280" } }, { "@type": "ScholarlyArticle", "name": "Dynamic topography analysis of the cornea and its application to the diagnosis of keratoconus.", "datePublished": "2023-03-21", "url": "https://questionsmedicales.fr/article/36966554", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.compbiomed.2023.106800" } }, { "@type": "ScholarlyArticle", "name": "Ocular Mycobacterium haemophilum infection originating in the cornea: a case report.", "datePublished": "2023-03-07", "url": "https://questionsmedicales.fr/article/36882753", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12879-023-08094-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines de transport", "item": "https://questionsmedicales.fr/mesh/D002352" }, { "@type": "ListItem", "position": 5, "name": "Protéines AAA", "item": "https://questionsmedicales.fr/mesh/D000074582" }, { "@type": "ListItem", "position": 6, "name": "ATPases associated with diverse cellular activities", "item": "https://questionsmedicales.fr/mesh/D000074183" }, { "@type": "ListItem", "position": 7, "name": "ATP-dependent proteases", "item": "https://questionsmedicales.fr/mesh/D049069" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : ATP-dependent proteases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur ATP-dependent proteases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur ATP-dependent proteases", "description": "Comment diagnostiquer une dysfonction des protéases ATP-dépendantes ?\nQuels tests sanguins sont utiles pour évaluer ces protéases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème avec ces enzymes ?\nPeut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux protéases ?", "url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Cornea&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur ATP-dependent proteases", "description": "Quels sont les symptômes d'une déficience en protéases ATP-dépendantes ?\nLes troubles neurologiques sont-ils liés à ces protéases ?\nComment la dégradation des protéines affecte-t-elle la santé ?\nY a-t-il des signes cutanés associés à ces troubles ?\nLes douleurs musculaires peuvent-elles être un symptôme ?", "url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Cornea&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur ATP-dependent proteases", "description": "Comment prévenir les troubles liés aux protéases ?\nL'exercice physique joue-t-il un rôle préventif ?\nLes contrôles médicaux réguliers sont-ils importants ?\nY a-t-il des vaccins pour prévenir ces troubles ?\nLe stress peut-il affecter la fonction des protéases ?", "url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Cornea&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur ATP-dependent proteases", "description": "Quels traitements existent pour les troubles liés aux protéases ?\nLes suppléments alimentaires peuvent-ils aider ?\nLa thérapie génique est-elle une option ?\nLes médicaments anti-inflammatoires sont-ils utiles ?\nComment la physiothérapie peut-elle aider ?", "url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Cornea&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur ATP-dependent proteases", "description": "Quelles complications peuvent survenir avec des troubles protéolytiques ?\nLes complications cardiovasculaires sont-elles possibles ?\nComment les troubles protéolytiques affectent-ils le système immunitaire ?\nY a-t-il un risque accru de cancer ?\nLes troubles neurologiques peuvent-ils s'aggraver ?", "url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Cornea&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur ATP-dependent proteases", "description": "Quels sont les facteurs de risque pour les troubles protéolytiques ?\nLe mode de vie influence-t-il ces risques ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe stress chronique est-il un facteur de risque ?\nL'exposition à des toxines peut-elle augmenter le risque ?", "url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Cornea&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des protéases ATP-dépendantes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des analyses protéomiques peuvent être utilisés." } }, { "@type": "Question", "name": "Quels tests sanguins sont utiles pour évaluer ces protéases ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des dosages d'enzymes spécifiques et des marqueurs de dégradation protéique sont recommandés." } }, { "@type": "Question", "name": "Les biopsies sont-elles nécessaires pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des biopsies peuvent aider à évaluer l'activité des protéases dans les tissus." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec ces enzymes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue, la perte de poids et des troubles métaboliques peuvent survenir." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux protéases ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie peut aider à visualiser des anomalies tissulaires, mais pas directement les protéases." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en protéases ATP-dépendantes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, troubles digestifs, et accumulation de protéines mal repliées peuvent se manifester." } }, { "@type": "Question", "name": "Les troubles neurologiques sont-ils liés à ces protéases ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dysfonctionnements peuvent entraîner des troubles neurologiques et cognitifs." } }, { "@type": "Question", "name": "Comment la dégradation des protéines affecte-t-elle la santé ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une dégradation inappropriée peut mener à des maladies dégénératives et à l'inflammation." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés à ces troubles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées et des problèmes de cicatrisation peuvent être observés." } }, { "@type": "Question", "name": "Les douleurs musculaires peuvent-elles être un symptôme ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs musculaires peuvent survenir en raison d'une dégradation protéique anormale." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés aux protéases ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à maintenir leur fonction." } }, { "@type": "Question", "name": "L'exercice physique joue-t-il un rôle préventif ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la santé musculaire et enzymatique." } }, { "@type": "Question", "name": "Les contrôles médicaux réguliers sont-ils importants ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bilans réguliers peuvent détecter précocement des anomalies protéolytiques." } }, { "@type": "Question", "name": "Y a-t-il des vaccins pour prévenir ces troubles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins spécifiques pour ces troubles enzymatiques." } }, { "@type": "Question", "name": "Le stress peut-il affecter la fonction des protéases ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber l'équilibre enzymatique et la santé cellulaire." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles liés aux protéases ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies enzymatiques et des médicaments ciblant les voies protéolytiques sont utilisés." } }, { "@type": "Question", "name": "Les suppléments alimentaires peuvent-ils aider ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains suppléments peuvent soutenir la fonction protéolytique et la santé cellulaire." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est explorée pour corriger des déficiences enzymatiques spécifiques." } }, { "@type": "Question", "name": "Les médicaments anti-inflammatoires sont-ils utiles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent réduire l'inflammation causée par une dégradation protéique anormale." } }, { "@type": "Question", "name": "Comment la physiothérapie peut-elle aider ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La physiothérapie peut améliorer la fonction musculaire et réduire la douleur associée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des troubles protéolytiques ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies dégénératives, des troubles métaboliques et des infections peuvent survenir." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles possibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres protéolytiques peuvent contribuer à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Comment les troubles protéolytiques affectent-ils le système immunitaire ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent affaiblir le système immunitaire, rendant l'organisme plus vulnérable aux infections." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de cancer ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans la dégradation des protéines peuvent être liées à certains cancers." } }, { "@type": "Question", "name": "Les troubles neurologiques peuvent-ils s'aggraver ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles protéolytiques non traités peuvent aggraver les symptômes neurologiques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles protéolytiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, des antécédents familiaux et des maladies métaboliques augmentent le risque." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il ces risques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent les risques." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent perturber la fonction des protéases et entraîner des complications." } }, { "@type": "Question", "name": "Le stress chronique est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la régulation des protéases et la santé globale." } }, { "@type": "Question", "name": "L'exposition à des toxines peut-elle augmenter le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines toxines peuvent altérer la fonction des protéases et causer des dommages cellulaires." } } ] } ] }

Sources (1270 au total)

New ZNF469 Mutations in Spanish Siblings With Brittle Cornea Syndrome.

The aim of this study was to describe the clinical, tomographic, and genetic findings of 2 Spanish siblings with brittle cornea syndrome and report a new mutation of gene ZNF469 implicated in the deve... In this study, 2 male siblings who had been diagnosed with brittle cornea syndrome underwent ophthalmologic and genetic assessment.... A novel homozygous deletion c.2972del, p.(Pro991Hisfs62) in the ZNF469 gene was identified in a Spanish family.... This is the first report of a ZNF469 mutation in a Spanish family causing brittle cornea syndrome. The discovery of this new mutation amplifies the spectrum of ZNF469 variants implicated in this syndr...

Dynamic topography analysis of the cornea and its application to the diagnosis of keratoconus.

To establish a dynamic topography analysis method which simulates the dynamic biomechanical response of the cornea and reveals the variations of such response within the corneal surface, and thereafte... 58 normal (Normal) and 56 keratoconus (KC) subjects were retrospectively included. Personalized corneal air-puff model was established using corneal topography data by Pentacam for each subject, and t... Corneal biomechanical parameters measured in different meridians varied significantly which were more pronounced in KC group due to its irregularity in corneal morphology. Considering such between-mer... The diagnosis of keratoconus may be affected by the significant variations of corneal biomechanical parameters due to corneal morphology irregularity. By considering such variations, the current study...

Ocular Mycobacterium haemophilum infection originating in the cornea: a case report.

Mycobacterium haemophilum is a slow-growing non-chromogenic nontuberculous Mycobacterium species that can cause skin infection or arthritis in an immunocompromised population or in children. Primary i... A 53-year-old healthy goldminer presented with left eye redness and a history of vision loss for four months. The patient was misdiagnosed with herpes simplex keratitis until M. haemophilum was detect... M. haemophilum could cause primary corneal infection in healthy adults, which is an infrequent or rare infection. Owing to the need for special bacterial culture conditions, conventional culture metho...

Characterization of the Immediate and Delayed Biomechanical Response to UV-A Crosslinking of Human Corneas.

Keratoconus leads to visual deterioration due to irregular astigmatism and corneal thinning. Riboflavin-based corneal UV-A crosslinking (CXL) induces novel intramolecular and intermolecular links resu... CXL was performed according to the Dresden protocol to corneas not suitable for transplantation. Biomechanical properties were subsequently monitored by measuring the Young modulus using nanoindentati... Young's modulus indicated a linear trend in direct response to increasing irradiation times (mean values: total 61.31 kPa [SD 25.53], 0 minutes 48.82 kPa [SD 19.73], 1 minute 53.44 kPa [SD 25.95], 15 ... This study suggests a linear increase of corneal Young modulus as a function of CXL timing. No significant short-term delayed biomechanical changes posttreatment were observed....

Customized Bowman-Stromal Inlay: An Attempt to Change the Topography of the Keratoconus Cornea.

The objective of this report is to describe a modification of a previously reported technique with an aim of improving the corneal topography and visual outcomes in progressive keratoconus along with ... In a 26-year-old man with progressive keratoconus, corneal collagen cross-linking was performed in one eye. The other eye had a keratometry of 69.6 D and thinnest pachymetry of 397 µm for which a cust... Stabilization of keratoconus could be achieved in the present case along with improvement in the corrected distance visual acuity and pachymetry. Maximum keratometry decreased from 69.6 D to 57.3 D.... Customized Bowman-stromal inlay technique appears to be a step towards creating an ideal inlay for the keratoconus cornea....